SelectQuote (SLQT) Stock News, Feb-Aug 2025

SelectQuote (NYSE:SLQT) announced the expanded launch of a new concierge-like service through its SelectRx pharmacy, designed to improve medication adherence for Medicare beneficiaries with multiple chronic conditions. A recent trial with a regional health plan demonstrated over 90% adherence, enhancing HEDIS Star ratings across triple-weighted measures for cholesterol, diabetes, and hypertension.

The program identifies high and medium-risk patients prone to adherence gaps, offering enhanced support through a clinical pharmacist team. The Company plans to expand to additional payers in 2025 and implement the program across SelectRx's pharmacy platform in 2026, reinforcing SelectQuote's evolution beyond traditional Medicare brokerage.

SelectQuote (NYSE:SLQT) announced the passing of William Thomas (Tom) Grant II, Vice Chairman and former President, on July 1, 2025. Grant played a crucial role in transforming SelectQuote from a term life insurance brokerage into a diversified insurance and healthcare services business over the past 15 years.

His sons, Bill Grant and Bob Grant, will continue their executive roles as Chief Operating Officer and President, respectively. SelectQuote, founded in 1985, operates through three core business lines: SelectQuote Senior for Medicare plans, SelectQuote Healthcare Services including SelectRx Pharmacy, and SelectQuote Life.

SelectQuote (NYSE: SLQT), a leading Medicare insurance policy distributor, has achieved a Net Promoter Score (NPS) of 58, categorized as "Great" by industry standards. The company was also recently included in USA Today's "America's Best Customer Service" list for 2025. The NPS score reflects high customer satisfaction, measuring the difference between "promoters" (scores 9-10) and "detractors" (scores 1-6).

Founded in 1985, SelectQuote operates through three core business lines: SelectQuote Senior (Medicare plans), SelectQuote Healthcare Services (including SelectRx Pharmacy and chronic care management), and SelectQuote Life. The company serves approximately 10,000 people turning 65 each day with Medicare Advantage and Medicare Supplement plans through its highly-trained agents and proprietary technology.

SelectQuote (NYSE: SLQT) reported its Q3 FY2025 results with consolidated revenue of $408.2 million, up from $376.4 million in Q3 FY2024. Net income reached $26.0 million, a significant increase from $8.6 million year-over-year, while Adjusted EBITDA was $37.7 million compared to $46.6 million in Q3 FY2024. The company's performance was driven by strong execution across segments: Senior generated revenue of $169.4 million with 168,001 approved Medicare Advantage policies, Healthcare Services achieved revenue of $189.6 million with 105,523 SelectRx members (41% YoY growth), and Life segment revenue reached $45.8 million. For FY2025, SelectQuote expects revenue between $1.500-$1.575 billion and net income ranging from $(1) million to $28 million.

SelectQuote (NYSE: SLQT) has issued a strong response to recent Department of Justice (DoJ) allegations regarding the Medicare Advantage industry. The company, which has been operating for over 40 years and served more than 8 million Americans, firmly rejects the DoJ's complaint and states it will defend its reputation. SelectQuote emphasizes that it has been cooperating with DoJ inquiries since 2022 and maintains that the allegations are incorrect and demonstrate a lack of understanding of their business model. The company particularly highlights its work with underserved communities, noting that their customer base includes a higher proportion of low-income seniors and individuals with chronic diseases compared to national averages, with dual special needs plan qualifiers at twice the national rate.

SelectQuote (NYSE: SLQT), a leading Medicare insurance policy distributor and healthcare services platform provider, has scheduled its fiscal third quarter 2025 earnings release for May 12, 2025, before market open. The company will host a conference call on the same day at 8:30 am ET, featuring CEO Tim Danker and CFO Ryan Clement to discuss the quarterly results.

Interested participants can register for the conference call through a provided link, with registration remaining open through the live call. The event will also be available via webcast on SelectQuote's investor relations website.

SelectQuote (NYSE: SLQT) has successfully closed a $350 million strategic investment from Bain Capital, Morgan Stanley Private Credit, and Newlight Partners on February 28, 2025. The company, which specializes in Medicare insurance policy distribution and healthcare services, has allocated $260 million of the proceeds to reduce its outstanding term loan.

Following this transaction, SelectQuote now maintains over $100 million in available liquidity to support its insurance distribution and healthcare services operations. The deal also brings strategic leadership additions, with Chris Wolfe from Bain Capital Insurance and Srdjan Vukovic from Newlight Partners joining the Board of Directors, each contributing over 20 years of investing and healthcare sector expertise.

SelectQuote (NYSE: SLQT) has secured a $350 million strategic investment from Bain Capital, Morgan Stanley Private Credit, and Newlight Partners. This investment will help the company recapitalize its balance sheet, reduce annual cash debt service, and provide liquidity for growth initiatives. The company has also successfully renegotiated its Senior Secured Credit Facility at a lower interest rate.

As part of the transaction, Chris Wolfe from Bain Capital and Srdjan Vukovic from Newlight Partners will join SelectQuote's Board of Directors upon closing, expected on February 28, 2025. Both executives bring over 20 years of healthcare sector experience. The deal follows SelectQuote's 2024 receivables securitization, marking progress toward refinancing and deleveraging goals.

SelectQuote (NYSE: SLQT) reported strong Q2 FY2025 results with consolidated revenue of $481.1 million, up from $405.4 million in Q2 FY2024. Net income reached $53.2 million, significantly higher than $19.4 million in the previous year. Adjusted EBITDA grew to $87.5 million from $67.4 million.

The Senior segment generated revenue of $255.6 million with Adjusted EBITDA of $100.5 million, achieving a 39% margin. Healthcare Services revenue was $183.4 million with SelectRx members growing 54% year-over-year to 96,695. Life segment revenue reached $39.9 million.

The company announced a $350 million strategic investment led by Bain Capital and Morgan Stanley Private Credit. For FY2025, SelectQuote expects revenue between $1.500-1.575 billion, net income between $(24) million to $11 million, and Adjusted EBITDA of $115-140 million.